Patent · US Active

Proteasome inhibitors

US7442830B1 · kind B1 · utility

62Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2007
Grant dateOct 28, 2008
Priority date
Expiry dateAug 6, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.